Search This Blog

Thursday, October 14, 2010

Castle's cloning coverup

Rep. Castle
Primary voters may have kicked Delaware Republican Rep. Michael Castle out of the House, but his deceptive and deadly bill to fund human cloning lives on.
Rather than pragmatically funding the proven and non-controversial adult stem cell research that is already providing help and hope for real patients, stubborn ideologues like Castle have ignored the evidence and determined instead to fund human cloning and lethal experimentation on living human embryos.
President Obama continues to shovel out hundreds of millions of dollars to speculative embryo-killing stem cell research, despite the clear illegality of doing so. That's why two adult-stem-cell scientists, James L. Sherley and Theresa Deisher, along with the Christian Medical Association and others, filed a lawsuit to enforce the federal law that clearly bans federal funding of “the creation of a human embryo ... for research purposes” and “research in which a human embryo or embryos are destroyed.”
U.S. District Court Judge Royce Lamberth agreed with our arguments and temporarily halted the federally funded embryo destruction. That ruling infuriated the "clone and kill" crowd in Congress, who refocused on passing Castle's bill, “The Stem Cell Research Advancement Act” (H.R. 4808) before voters kicked more of them out of office.
By deploying semantics and sophistry, Castle's bill would actually authorize federal funding of human-cloning research. The bill craftily redefines “human cloning” as implanting a cloned embryo in a womb, rather than using the obvious definition of creating an embryo through cloning. By allowing the creation of a clone but barring her implantation, the bill actually mandates killing the cloned human being.
It's time for voters to demand that their politicians stop funding illegal, lethal and unethical research and instead focus on the proven and effective adult stem cell research that offers infinitely greater potential to help real patients right now.

1 comment:

Anonymous said...

Business intelligence healthcare
business intelligence healthcare